Insider Transactions in Q4 2021 at Medifast Inc (MED)
Insider Transaction List (Q4 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 31
2021
|
Daniel R Chard Chairman & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
11,533
-28.99%
|
$2,410,397
$209.43 P/Share
|
|
Dec 31
2021
|
Daniel R Chard Chairman & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
24,072
+37.7%
|
-
|
|
Nov 11
2021
|
Kevin G Byrnes Director |
SELL
Payment of exercise price or tax liability
|
Direct |
6,149
-29.18%
|
$1,401,972
$228.45 P/Share
|
|
Nov 11
2021
|
Kevin G Byrnes Director |
BUY
Exercise of conversion of derivative security
|
Direct |
12,917
+21.25%
|
$361,676
$28.58 P/Share
|
|
Nov 08
2021
|
Jeffrey J Brown Director |
BUY
Open market or private purchase
|
Indirect |
4,199
+1.25%
|
$961,571
$229.55 P/Share
|
|
Nov 04
2021
|
Daniel R Chard Chairman & CEO |
BUY
Bona fide gift
|
Indirect |
90,610
+50.0%
|
-
|
|
Nov 04
2021
|
Daniel R Chard Chairman & CEO |
SELL
Bona fide gift
|
Direct |
90,610
-85.22%
|
-
|